2m 2m 2m 2m 2m 2m 2m
DBV TECHNO SP ADR (DBVT)
NASDAQ
$17.75+$0.05 (+0.28%)
Price as of Jun 03, 2026 4:10 PM EDT- $1.1BMarket Cap
- 129.60%1-Year Change
- BiotechnologyIndustry
DBV TECHNO SP ADR (DBVT)
$17.75+$0.05 (+0.28%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.6M +35.77% | 4.2M -73.61% | 15.7M +224.69% | 4.8M -15.14% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 5.6M +35.77% | 4.2M -73.61% | 15.7M +224.69% | 4.8M -15.14% | |
Sales and Marketing Expense | 3.2M +21.17% | 2.7M +9.06% | 2.4M +51.62% | 1.6M -63.35% | |
Research and Development Expense | -116.7M +30.60% | -89.3M +48.35% | -60.2M -20.28% | -75.5M +7.40% | |
Depreciation and Amortization Expense | 2.7M +16.71% | 2.3M -36.83% | 3.6M +33.33% | 2.7M -38.64% | |
Total Operating Expenses | 152.7M +26.46% | 120.7M +31.01% | 92.2M -9.18% | 101.5M -2.73% | |
Operating Profit | -147.1M -229.09% | 113.9M +249.04% | -76.4M -20.90% | -96.6M -2.01% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | -146.5M -228.56% | 113.9M +256.66% | -72.7M -24.41% | -96.2M -2.02% | |
Income Taxes | 491,000 +792.73% | 55,000 +685.71% | 7,000 -90.00% | 70,000 +118.37% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -146.9M -228.99% | 113.9M +256.64% | -72.7M -24.46% | -96.3M -1.57% | |
Net Income from Continuing Operations Applicable to Common | -146.5M -228.56% | 113.9M +256.66% | -72.7M -24.41% | -96.2M -2.02% | |
Basic EPS and Net Income | -1.05 -10.26% | -1.17 +53.95% | -0.76 -38.71% | -1.24 -30.34% | |
Diluted EPS and Net Income | -1.05 -10.26% | -1.17 +53.95% | -0.76 -38.71% | -1.24 -30.34% | |
Basic Weighted Average Shares | 139.6M +43.90% | 97.0M +1.97% | 95.1M +22.92% | 77.4M +40.91% | |
Diluted Weighted Average Shares | 139.6M +43.90% | 97.0M +1.97% | 95.1M +22.92% | 77.4M +40.91% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 194.2M +498.25% | 32.5M -77.04% | 141.4M -32.42% | 209.2M +170.62% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 194.2M +498.25% | 32.5M -77.04% | 141.4M -32.42% | 209.2M +170.62% | |
Total Current Assets | 212.9M +379.73% | 44.4M -72.07% | 158.9M -28.76% | 223.1M +95.02% | |
Accumulated Depreciation | 19.6M +31.61% | 14.9M -21.33% | 19.0M +28.17% | 14.8M +7.17% | |
Property and Plant and Equipment and Net | 10.4M -8.28% | 11.3M -10.43% | 12.6M -16.38% | 15.1M -16.81% | |
Total Long-Term Assets | 20.8M -2.33% | 21.3M -11.63% | 24.1M +2.67% | 23.4M -27.50% | |
Total Assets | 233.7M +255.96% | 65.7M -64.12% | 183.0M -25.77% | 246.5M +68.02% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 2.6M +31.68% | |
Total Current Liabilities | 58.0M +86.36% | 31.1M -16.61% | 37.3M +26.48% | 29.5M -5.98% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 510,000 -71.30% | |
Total Long-Term Liabilities | 6.9M -2.97% | 7.1M +30.65% | 5.5M -75.78% | 22.5M +40.44% | |
Total Liabilities | 64.9M +69.71% | 38.3M -10.58% | 42.8M -17.80% | 52.1M +9.73% | |
Retained Earnings | -393.1M +37.28% | -286.4M +19.89% | -238.9M -7.98% | -259.6M +0.41% | |
Total Stockholders Equity | 168.8M +516.24% | 27.4M -80.46% | 140.2M -27.91% | 194.5M +95.88% | |
Total Shares Outstanding | 235.7M +129.15% | 102.8M +6.65% | 96.4M +2.44% | 94.1M +1,735.60% | |
Cash Flow | |||||
Cash from Operating Activities | -121.2M +15.99% | -104.5M +31.16% | -79.7M +43.09% | -55.7M -48.57% | |
Capital Expenditures | 532,000 -77.25% | 2.3M +245.35% | 677,000 -10.21% | 754,000 -17.14% | |
Cash from Investing Activities | -1.4M +80.85% | -757,000 -6.31% | -808,000 +708.00% | -100,000 -76.91% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 276.2M +46,949.74% | 587,000 -91.33% | 6.8M -96.51% | 194.1M +70,746.72% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -2,609.23% -195.08% | 2,744.35% +664.73% | -485.96% -75.64% | -1,994.86% +15.47% | |
Return on Assets | -98.17% -207.13% | 91.63% +370.58% | -33.87% -30.84% | -48.96% +4.87% | |
Return on Equity | -149.83% -210.20% | 135.96% +412.81% | -43.47% -33.69% | -65.55% +2.13% | |
Revenue Growth | 35.77% +148.60% | -73.61% -132.76% | 224.69% +1,584.41% | -15.14% -69.35% | |
Current Ratio | 3.67 +157.42% | 1.43 -66.50% | 4.26 -43.68% | 7.56 +107.41% | |
Cash Ratio | 3.35 +221.02% | 1.04 -72.47% | 3.79 -46.57% | 7.09 +187.82% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.02 -57.67% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.01 -50.78% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow